Invitrogen Corporation

(NASDAQ:IVGN)

Key Stats & Ratios

Valuation
Market Cap 2.34B
P/E 13.80
P/E (Trailing) 13.39
P/E (Forward)
Price/Sales 1.58
Price/Book 1.21
EPS 1.83
EPS Growth (ttm) 2514.00%
Fiscal Year
Fiscal Year Ends Dec 31
Last Quarter Jun 2008
Profitability
Operating Income 239.55M
Net Income 179.23M
Profit Margin (ttm) 12.70%
Operating Margin (ttm) 0.16%
Management Effectiveness
Return on Assets (ttm) 5.30%
Return on Equity (ttm) 9.70%
EBIT Margin (ttm) 18.90
Memberships
S&P Small Cap, Russel 1000
SEC Filings
Latest Form 10-Q (Quartely)
Latest Form 10-K (Annual)

Financials

Income Statement
Total Enterprise Value 2.71B
Revenue 1.42B
Revenue/Share 15.33
Revenue Growth (ytd) 14.20%
Annual Revenue Growth Rate (3Y) 5.12%
Annual Income Growth Rate (3Y)
Earnings Growth (ytd) 35.30%
Gross Operating Profit (ttm) 965.48M
EBITDA 384.62M
Diluted EPS (ttm) 1.83
Balance Sheet
Total Cash 673.29M
Total Cash/Share 7.29
Total Assets 3.40B
Total Liabilities 1.55B
Total Debt/Equity
Long Term Debt Common Equity Ratio 0.62
Current Ratio 4.00
Leverage Ratio 1.00
Book Value/Share 19.94
Cash Flow
Cash Flow 288.46M
Free Cash Flow 103.72M
Cash Flow/Share 3.12
Free Cash Flow/Share 1.12

Trading Information

Stock Price History
Beta
52Wk Change -47.50%
52Wk Change Vs. Mkt -21.00%
52Wk High 49.00
52Wk Low 19.56
10 Day Moving Average 23.13
200 Day Moving Average 36.96
Share Statistics
Average Volume 1.77M
Shares Outstanding 92.36M
Shares Float 91.98M
% Held by Insiders 0.40%
% Held by Institutions 99.40%
Shares Short (As of Oct 28, 2008) 17.24M
Short Ratio 5.70
Short % of Float 18.70%
Dividends & Splits
Dividend Date
Dividend Yield
Dividend Amount